Mike Conover: prediction

Transcript context

…Yeah. And I think that's the main difference about what you're doing. It's not about summarizing. It's about coming up with different ideas and kind of like thought threads to pull on. Yeah. You know, if I think that GLP-1s are going to blow up the diet industry, identifying and putting in context a negative result from a human clinical trial, or for example, that adherence rates to Ozempic after a year are just 35%, what are the implications of this? So there's an information retrieval component. And then there's a not just presenting me with a summary of like, here's here are the facts, but like, what does this entail? And how does this fit into my worldview, my fund strategy? Broadly, I think that, you know, I mean, this idea, I think, is very eloquently puts it, which is, and this is not my insight, but that language models, and help me know who said this. You may be familiar, but language models are not tools for creating new knowledge. They're tools for helping me create new knowledge. Like they themselves do not do that. I think that that's presently the right way to think about it. Yeah. I've read a tweet about Needle in the Haystack actually being harmful to some of this work because now the model is like too focused on recalling everything versus saying, oh, that doesn't matter. Like ignoring some of the things, if you think about a S1 filing, like 85% is like boilerplate. It's like, you know, previous performance doesn't guarantee future performance. Like the company might not be able to turn a profit in the future, blah, blah, blah. All these things, they always come up again.…

Stored transcript either side of the excerpt. The highlighted words are the published quote; the surrounding text is unedited source, never generated.